Are Epstein-Barr Virus-positive and -Negative Gastric Carcinomas, with Lymphoid Stroma, Single Entity or Different Entities?
Wei Kang,Ka Fai To
DOI: https://doi.org/10.1016/j.cgh.2015.06.024
IF: 13.576
2015-01-01
Clinical Gastroenterology and Hepatology
Abstract:Gastric cancer (GC) remains one of the leading causes of cancer-related mortality in the world.1Siegel R. Naishadham D. Jemal A. Cancer statistics, 2013.CA Cancer J Clin. 2013; 63: 11-30Crossref PubMed Scopus (11509) Google ScholarHelicobacter pylori infection is known to be an important etiologic factor.2Prinz C. Schwendy S. Voland P. H pylori and gastric cancer: shifting the global burden.World J Gastroenterol. 2006; 12: 5458-5464PubMed Google Scholar Epstein-Barr virus (EBV) is another infectious agent implicated in gastric carcinogenesis. EBV infection in the carcinoma cells can be demonstrated in a subset of GC, most reported in the range of 2%–20 % of all GC.3Shinozaki-Ushiku A. Kunita A. Fukayama M. Update on Epstein-Barr virus and gastric cancer.Int J Oncol. 2015; 46: 1421-1434PubMed Google Scholar, 4Shibata D. Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma.Am J Pathol. 1992; 140: 769-774PubMed Google Scholar, 5Tokunaga M. Land C.E. Uemura Y. et al.Epstein-Barr virus in gastric carcinoma.Am J Pathol. 1993; 143: 1250-1254PubMed Google Scholar Burke et al6Burke A.P. Yen T.S. Shekitka K.M. et al.Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction.Mod Pathol. 1990; 3: 377-380PubMed Google Scholar first reported the association between EBV infection and GC with characteristic lymphoepithelioma-like histology that was based on polymerase chain reaction techniques in 1990. In subsequent studies, EBV infection was demonstrated by in situ hybridization (ISH) of EBV-encoded small RNAs (EBERs) in the GC cells, which could have lymphoepithelioma-like histology or conventional gastric carcinoma morphology.7Oda K. Tamaru J. Takenouchi T. et al.Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma.Am J Pathol. 1993; 143: 1063-1071PubMed Google Scholar, 8Nakamura S. Ueki T. Yao T. et al.Epstein-Barr virus in gastric carcinoma with lymphoid stroma: special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis.Cancer. 1994; 73: 2239-2249Crossref PubMed Scopus (175) Google Scholar On the basis of recent review, EBV-associated GC (EBVaGC) comprises an average of nearly 10% crude prevalence in GC cases worldwide.9Corvalan A. Ding S. Koriyama C. et al.Association of a distinctive strain of Epstein-Barr virus with gastric cancer.Int J Cancer. 2006; 118: 1736-1742Crossref PubMed Scopus (46) Google Scholar, 10Murphy G. Pfeiffer R. Camargo M.C. et al.Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.Gastroenterology. 2009; 137: 824-833Abstract Full Text Full Text PDF PubMed Scopus (333) Google Scholar EBVaGC has been reported to be associated with rather distinct clinicopathologic features, including more predominant in men, proximal in location, diffuse subtype, and less frequent lymph node metastasis.9Corvalan A. Ding S. Koriyama C. et al.Association of a distinctive strain of Epstein-Barr virus with gastric cancer.Int J Cancer. 2006; 118: 1736-1742Crossref PubMed Scopus (46) Google Scholar, 11Lee J.H. Kim S.H. Han S.H. et al.Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.J Gastroenterol Hepatol. 2009; 24: 354-365Crossref PubMed Scopus (195) Google Scholar EBVaGC also predicts better survival of patients with GC. However, the histomorphologic features of EBVaGC are variable. These could be conventional GC (intestinal or diffuse type morphology) or GC associated with dense lymphoid stroma. GC with lymphoid stroma (GCLS) is regarded as a morphologic variant of GC. GCLS contained typical undifferentiated carcinoma morphology and variable amount of conventional GC components. The incidence of GCLS was reported in the range of 1%–4% of all GC.8Nakamura S. Ueki T. Yao T. et al.Epstein-Barr virus in gastric carcinoma with lymphoid stroma: special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis.Cancer. 1994; 73: 2239-2249Crossref PubMed Scopus (175) Google Scholar, 10Murphy G. Pfeiffer R. Camargo M.C. et al.Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.Gastroenterology. 2009; 137: 824-833Abstract Full Text Full Text PDF PubMed Scopus (333) Google Scholar, 12Takada K. Epstein-Barr virus and gastric carcinoma.Mol Pathol. 2000; 53: 255-261Crossref PubMed Scopus (270) Google Scholar Most but not all cases of GCLS were EBV-positive. Because the incidence of GCLS is low, the possible clinicopathologic features and prognostic implication were unclear. It is also uncertain whether EBV-positive GCLS and EBV-negative GCLS represent similar or distinct entities. In this issue of Clinical Gastroenterology and Hepatology, Lim et al13Lim H. Park Y.S. Lee J.H. et al.Features of gastric carcinoma with lymphoid stroma associate with Epstein-Barr virus.Clin Gastroenterol Hepatol. 2015; 13: 1738-1744PubMed Google Scholar retrospectively reviewed 16,398 GC surgical resection samples and identified 274 cases (1.7%) of GCLS. The incidence of GCLS (1.7%) is similar to the other reported series.8Nakamura S. Ueki T. Yao T. et al.Epstein-Barr virus in gastric carcinoma with lymphoid stroma: special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis.Cancer. 1994; 73: 2239-2249Crossref PubMed Scopus (175) Google Scholar, 10Murphy G. Pfeiffer R. Camargo M.C. et al.Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.Gastroenterology. 2009; 137: 824-833Abstract Full Text Full Text PDF PubMed Scopus (333) Google Scholar, 12Takada K. Epstein-Barr virus and gastric carcinoma.Mol Pathol. 2000; 53: 255-261Crossref PubMed Scopus (270) Google Scholar Nevertheless, the current study represented the largest cohort of GCLS and was more informative to clarify the clinicopathologic features of EBV-positive and EBV-negative GCLS. In this study, GCLS group (274 cases) was first compared with the control group (822 cases) of conventional GC. GCLS was shown to be associated with more advanced macroscopic type, proximal location, multiple lesions, and higher T stage, whereas the American Joint Committee on Cancer stages of the GCLS patients were similar to the control group. GCLS also showed better disease-specific survival. The clinicopathologic features of GCLS were basically similar to other reported series.14Park S. Choi M.G. Kim K.M. et al.Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.J Surg Res. 2015; 194: 458-463Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar, 15Chang M.S. Kim W.H. Kim C.W. et al.Epstein-Barr virus in gastric carcinomas with lymphoid stroma.Histopathology. 2000; 37: 309-315Crossref PubMed Scopus (38) Google Scholar Within the GCLS group, EBV-positive GCLS was more prevalent than EBV-negative GCLS, and the 2 groups constituted 86.1% and 13.9%, respectively. When compared with EBV-negative GCLS, EBV-positive cases were more common in younger patients, proximal location, early macroscopic type, and better disease-specific survival. When compared with conventional GC, only EBV-positive GCLS associated with better disease-specific survival and remained as an independent prognostic factor in multivariate analysis. The prognostic implication was even more apparent and significant in the advanced stage GCs (stages III and IV). The prognostic association was not influenced by the amount of conventional GC component in the EBV-positive GCLS. EBV-negative GCLS did not demonstrate an association with better survival. In contrast, it might correlate with poorer survival, although not reaching statistical significance. The findings supported that the most important prognostic factor in GCLS is the presence of EBV infection in the carcinoma cells but does not depend on the carcinoma cell morphology. In this study, the EBV status in the control group was unknown. Thus, one could not further analyze the possible differences in clinicopathologic features between EBV-positive conventional GC versus EBV-positive GCLS. Currently, testing for EBV status in GC is not routinely requested. However, in view of the prognostic implication as revealed by the literature, EBV status in GC may serve as a clinically useful prognostic marker.13Lim H. Park Y.S. Lee J.H. et al.Features of gastric carcinoma with lymphoid stroma associate with Epstein-Barr virus.Clin Gastroenterol Hepatol. 2015; 13: 1738-1744PubMed Google Scholar EBV status may also have potential therapeutic implications. Histologic features may provide hints to the presence of EBV in GC. GC displaying typical morphologic features of lymphoepithelioma-like carcinoma, GCLS, or rarely carcinoma with Crohn’s disease–like lymphoid reaction would have a higher probability of harboring EBV latent infection.16Song H.J. Kim K.M. Pathology of epstein-barr virus-associated gastric carcinoma and its relationship to prognosis.Gut Liver. 2011; 5: 143-148Crossref PubMed Scopus (39) Google Scholar Nevertheless, GC with conventional histology, either intestinal or diffuse type, may also harbor EBV. Thus, one needs to test for EBV in all GC cases to diagnose all EBVaGCs. ISH for EBERs is the current gold standard to detect EBV in the carcinoma cells.3Shinozaki-Ushiku A. Kunita A. Fukayama M. Update on Epstein-Barr virus and gastric cancer.Int J Oncol. 2015; 46: 1421-1434PubMed Google Scholar The carcinoma cells harboring EBV latent infection contain abundant EBERs transcripts. ISH for EBERs is applicable in routine formalin-fixed paraffin-embedded tissue sections and allows visualization of the EBV-infected carcinoma cells. Immunohistochemical staining for EBV-expressed viral proteins, like LMP2 or LMP1, is not recommended for the identification of EBV infection because the expression level of these viral proteins tends to be low, and the immunohistochemistry is not sensitive enough for detection. Circulating EBV DNA in blood samples from patients with EBVaGC has been reported and suggested to be a potential biomarker for early diagnosis and monitoring.17Lo Y.M. Chan W.Y. Ng E.K. et al.Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma.Clin Cancer Res. 2001; 7: 1856-1859PubMed Google Scholar The clinical utility of detecting circulating EBV DNA in patients with EBVaGC remains to be determined. EBVaGC belongs to latency type I or II infection, in which EBERs, EBNA-1, BamHI A rightward transcript (BART), and BART miRNAs are expressed, and approximately half of EBVaGC cases express LMP2A viral protein.18Luo B. Wang Y. Wang X.F. et al.Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.World J Gastroenterol. 2005; 11: 629-633Crossref PubMed Scopus (130) Google Scholar LMP2A (in 36.4% of GC cases18Luo B. Wang Y. Wang X.F. et al.Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.World J Gastroenterol. 2005; 11: 629-633Crossref PubMed Scopus (130) Google Scholar), EBERs, and EBV-encoded miRNAs were implicated in the EBV-related carcinogenesis in GC.19Iwakiri D. Eizuru Y. Tokunaga M. et al.Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA.Cancer Res. 2003; 63: 7062-7067PubMed Google Scholar, 20Hino R. Uozaki H. Inoue Y. et al.Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.Cancer Res. 2008; 68: 1427-1435Crossref PubMed Scopus (81) Google Scholar, 21Marquitz A.R. Mathur A. Shair K.H. et al.Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.Proc Natl Acad Sci U S A. 2012; 109: 9593-9598Crossref PubMed Scopus (84) Google Scholar The precise mechanisms how EBV infection leads to EBVaGC are still unclear. Recent large-scale comprehensive genomic studies proposed a molecular classification of GC that defines 4 major subtypes including chromosomally unstable, genomically stable, microsatellite instability, and EBV-positive GC.22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar The whole-genome CpG hypermethylation that causes downregulation of gene expression is one of the main molecular features in EBVaGC.22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar Induction of global extreme promoter hypermethylation in EBVaGC is linked to upregulation of DNA methyltransferase-3b through LMP2A.23Zhao J. Liang Q. Cheung K.F. et al.Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.Cancer. 2013; 119: 304-312Crossref PubMed Scopus (109) Google Scholar EBVaGC has high somatic mutation rates in PIK3CA, ARID1A, and gene amplification of JAK2.22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar, 24Gulley M.L. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.Exp Mol Med. 2015; 47: e134Crossref PubMed Scopus (54) Google Scholar, 25Wang K. Kan J. Yuen S.T. et al.Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.Nat Genet. 2011; 43: 1219-1223Crossref PubMed Scopus (597) Google Scholar Thus, EBVaGC exhibited rather typical molecular signatures and is considered as a distinct molecular entity. EBVaGCs also have a recurrent amplified 9p24.1 locus linked to overexpression of CD274 (PD-L1) and PDCD1LG2 (PD-L2).22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar PD-L1 and PD-L2 expression is related to immune response. The specifically expanded cytotoxic T lymphocytes were reported to kill autologous EBV-transformed cells.26Kuzushima K. Nakamura S. Nakamura T. et al.Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.J Clin Invest. 1999; 104: 163-171Crossref PubMed Scopus (53) Google Scholar In addition, the deregulated genes in EBVaGC were enriched in immune response–related signaling pathway.22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar These molecular changes might allow EBVaGC to recruit more reactive immune cells, and this might contribute to the pathobiology and outcome of EBV-positive GC.27Kim S.Y. Park C. Kim H.J. et al.Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.Gastroenterology. 2015; 148: 137-147 e9Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar In this study, only EBV-positive GCLS correlates with better survival when compared with conventional GC, and EBV status serves as an independent prognosis factor. On the contrary, EBV-negative GCLS has a trend to be associated with poorer survival in advanced GCs. Thus, EBV infection is the most important prognosis factor in GCLS but not the cancer cell morphology.13Lim H. Park Y.S. Lee J.H. et al.Features of gastric carcinoma with lymphoid stroma associate with Epstein-Barr virus.Clin Gastroenterol Hepatol. 2015; 13: 1738-1744PubMed Google Scholar This study supported that EBV-positive and EBV-negative GCLS are 2 different entities. Although not all EBVaGCs are associated with GCLS histology, as a distinct molecular subtype of GC, EBVaGC has its distinct molecular changes such as whole-genome global CpG methylation, high mutation rate of PIK3CA, and amplification of JAK2 and PD-L1/2.22The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma.Nature. 2014; 513: 202-209Crossref PubMed Scopus (3912) Google Scholar Thus, EBVaGC represents a GC subtype that potentially has more actionable targets. Nearly 80% of EBVaGC cases were found to be harboring protein-changing alteration in PIK3CA, and this finding suggests the susceptibility to PI3 kinase inhibitors. The higher frequency of JAK2 gene amplification in EBVaGC implies that EBVaGC might also be susceptible to JAK2 inhibitors. Amplifications in PD-L1/2 in EBVaGC indicated that specific antibodies directly inhibiting these ligands might be effective. Brahmer et al28Brahmer J.R. Tykodi S.S. Chow L.Q. et al.Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.N Engl J Med. 2012; 366: 2455-2465Crossref PubMed Scopus (5831) Google Scholar conducted a phase 1 clinical trial to assess the safety and adverse-event profiles of anti–PD-L1 antibody (BMS-936559) in patients with selected advanced cancers. Seven GC patients were recruited in this study; none of them showed response to administration with anti–PD-L1 antibody.28Brahmer J.R. Tykodi S.S. Chow L.Q. et al.Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.N Engl J Med. 2012; 366: 2455-2465Crossref PubMed Scopus (5831) Google Scholar However, patients with GC enrolled in this study were not selected on the basis of EBV status and PD-L1/2 amplification or expression status. It is suggested that selection of patients in future clinical trial on the basis of EBV and PD-L1/2 status could be critical. The findings in this study supported that EBV-positive and EBV-negative GCLS are 2 different entities, despite sharing similar histomorphology. It would be of interest to characterize the infiltrative lymphoid cells and the microenvironment in both EBV-positive and EBV-negative GCLS and further explore the underlying mechanisms. EBVaGC can exhibit conventional GC or GCLS morphology. In view of the current understanding of the molecular subtypes and potential therapeutic implications, comparative studies between EBV-positive conventional GC and GCLS deserve further investigations. Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr VirusClinical Gastroenterology and HepatologyVol. 13Issue 10PreviewGastric carcinoma with lymphoid stroma (GCLS) is a distinct histologic subtype of gastric cancer that is characterized by undifferentiated carcinoma mixed with prominent lymphoid infiltration. More than 80% of GCLS cases are associated with Epstein–Barr virus (EBV) infection, but it is unclear if the virus affects disease progression. We investigated how EBV infection affects the clinical and pathologic features of GCLS, as well as patients’ outcomes. Full-Text PDF